Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoposide and Cisplatin for Recurrent Ependymomas
NCT00002876Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 1991
- Primary completion
- Apr 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, etoposide in ependymoma, sponsored by Mayo Clinic. Started Oct 1991; status: completed.
02
Drugs
cisplatinetoposide
03
Conditions
ependymoma
Beyond the preview
Go deeper on NCT00002876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002876.